Nutex Health (NUTX) Capital Leases (2021 - 2026)

Nutex Health's Capital Leases history runs 6 years deep, the most recent figure standing at $268.8 million for Q1 2026.

• In Q1 2026, Capital Leases rose 4.02% year-over-year to $268.8 million; the TTM figure through Mar 2026 stood at $268.8 million (up 4.02% YoY), while the FY2025 annual figure was $268.9 million, up 3.62% from the prior year.
• Capital Leases came in at $268.8 million for Q1 2026 at Nutex Health, roughly flat from $268.9 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $270.1 million in Q3 2025 to a low of $192.5 million in Q2 2022.
• A 5-year average of $236.5 million and a median of $233.9 million in 2024 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases surged 209.76% in 2022 and decreased 8.67% in 2024, its largest moves.
• Nutex Health's Capital Leases stood at $203.6 million in 2022, then grew by 5.04% to $213.9 million in 2023, then climbed by 21.32% to $259.5 million in 2024, then gained by 3.62% to $268.9 million in 2025, then fell by 0.04% to $268.8 million in 2026.
• According to Business Quant data, Capital Leases over the past three periods registered $268.8 million, $268.9 million, and $270.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison